Active Ingredient
Chlorhexidine gluconate 4% solution
The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health for the product Antiseptic Skin Cleanser (NDC 70000-0407). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, do not use, when using this product, stop use and ask a doctor if, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Chlorhexidine gluconate 4% solution
Antiseptic
For external use only
Allergy alert:
This product may cause a severe allergic reaction. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
irritation, sensitization, or allergic reaction occurs. These may be signs of a serious condition.
If swallowed, get medical help or contact a Poison Control Center right away.
Healthcare personnel handwash:
Skin wound and general skin cleansing:
cocamide DEA, fragrance, glucono-delta-lactone, hydroxyethylcellulose, isopropyl alcohol, lauramine oxide, PEG-75 lanolin, purified water, tridecyl alcohol
1-800-587-3721
Laundering/cleaning instructions:
Chlorhexidine gluconate skin cleansers will cause stains if used with chlorine releasing products, such as chlorine bleach.
*This product is not manufactured or districuted by Regent Medical Limited (United Kingdom Corp.), owner of the registered trademark Hibiclens ®.
WARNING: Cancer - www.P65Warnings.ca.gov
NDC 70000-0407-1
Leader
Antisptic Skin Cleanser
Chlorhexidine Gluconate 4% Solution
Antiseptic/Antimicrobial Skin Cleanser
Great For Hand Hygiene
For Skin Wound and General Skin Cleansing
Compare To Hibiclens® active ingredients*
For External Use Only
8 fl (237 mL)
Tampering evident:
Do not use if shrink seal neackband is broken or missing
CIN 5454889 REV. 8/23
* Please review the disclaimer below.